Stay updated with the latest on HVAX Technologies IPO GMP (Grey Market Premium). We provide live data and key information to help you make informed investment decisions.
HVAX Technologies IPO GMP Overview
- IPO Open Date: September 27, 2024
- IPO Close Date: October 01, 2024
- Price Band: ₹435 to ₹458 per share
- Issue Size: ₹33.53 Crores
- Listing Date: October 07, 2024
- Lot Size: Minimum 350 shares(₹137,400)
HVAX Technologies IPO GMP Live Rates
| Dates | IPO GMP |
|---|---|
| October 07, 2024 | ₹25 (5%) |
| October 06, 2024 | ₹25 (5%) |
| October 05, 2024 | ₹25 (5%) |
| October 04, 2024 | ₹15 (3%) |
| October 03, 2024 | ₹15 (3%) |
| October 02, 2024 | ₹15 (3%) |
| October 01, 2024 | ₹- |
| September 30, 2024 | ₹- |
| September 29, 2024 | ₹- |
| September 28, 2024 | ₹- |
| September 27, 2024 | ₹- |
| September 26, 2024 | ₹- |
| September 25, 2024 | ₹- |
| September 24, 2024 | ₹- |
IPO Timeline
| Events | Date |
|---|---|
| IPO Open Date | September 27, 2024 |
| IPO Close Date | October 1, 2024 |
| Basis of Allotment | October 3, 2024 |
| Refunds | October 4, 2024 |
| Credit to Demat Account | October 4, 2024 |
| IPO Listing Date | October 7, 2024 |
About HVAX Technologies
Hvax Technologies Limited, initially established at 601, Lodha Supremus, I-Think Techno Campus, Kanjurmarg (East), Mumbai – 400042, Maharashtra, was incorporated as a Private Limited company on November 26, 2010, under the Companies Act, 1956. The conversion from a private limited company to a public limited company was approved during an Extra Ordinary General Meeting held on December 11, 2023, with the official name change to Public Limited occurring on January 8, 2024.
The company specializes in executing turnkey projects related to engineering, procurement, and the creation of controlled environment infrastructure and cleanrooms. Additionally, they provide design, engineering, and consultancy services specifically for the pharmaceutical and healthcare sectors. Their consultancy services include engineering guidance, GAP analysis and validation, containment solutions, technology transfer, and project feasibility assessments for clients within the pharmaceutical space.
With a diversified business model that extends across various customers and regions, Hvax Technologies maintains a strong focus on customer satisfaction. Their client base consists of companies that benefit from both turnkey solutions and equipment supply, as well as design, engineering, and consultancy services within the pharma and healthcare industries. On August 31, 2024, the company employed 125 permanent employees and 21 temporary and agency workers.
Disclaimer
- The Grey Market Premium (GMP) mentioned for (HVAX Technologies IPO GMP) is applicable only for the specific date provided.
- We do not engage in the buying or selling of IPO forms on the grey market.
- Please do not base your IPO subscription decision solely on the premium price, as it may fluctuate. Always consider the company’s fundamentals before investing.
For the latest news on Upcoming IPOs and IPO GMP, follow IPOGMP.IN. Additionally, connect with us on Twitter, Facebook, and Instagram.
